Invention Grant
- Patent Title: Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2
-
Application No.: US14623089Application Date: 2015-02-16
-
Publication No.: US09938339B2Publication Date: 2018-04-10
- Inventor: Gavin Thurston , Christopher Daly
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Schwabe, Williamson & Wyatt P.C.
- Agent Aparna G. Patankar; Thomas Triolo
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61K31/513 ; A61K38/18 ; A61K45/06 ; A61K39/00
Abstract:
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.
Public/Granted literature
- US20150152177A1 High Affinity Human Antibodies to Human Angiopoietin-2 Public/Granted day:2015-06-04
Information query
